HOW INDIA STOOD UP TO IT’s TITLE AS “PHARMACY OF THE WORLD” DURING COVID-19 CRISIS
AUTHORED BY - ASHUTOSH TRIPATHI
These are exceptional times for the strong and independent India, where a public healthcare disaster has taken the world to a position where almost everybody is becoming submissive, countries are giving up and losing all hopes. For all that we know, the last time such global panic and terror prevailed was during the World Wars. The discussion on human culpability in the spread of the novel coronavirus Covid-19 has just started and is probably going to overwhelm global talk and governmental issues for times to come.[1] The main aim of India is to focus on the prevention, mitigation and control of Covid-19 not only in India but also at the same time helping its immediate neighbour as much as possible and also helping the world as far as possible. Though India is one of the worst hit Covid-19 crisis country but still it proved that why it is hailed as the “Pharmacy of the world”. Even India wrestles with the spread of the coronavirus infection inside, it has stretched out its assistance to adjoining nations like Bangladesh, Sri Lanka, Bhutan and Nepal — all nations having a place with the South Asian Association for Regional Cooperation (SAARC) and also the world at large as much as possible.
India stood by its traditional ethos of its humanitarian approach and implementing the vaccine diplomacy vis-à-vis COVID-19 pandemic, India had sent the teams of Indian military doctors to the countries like Nepal, the Maldives and Kuwait to help the local administrations draw up plans to combat the spread of the COVID-19 pandemic .Not, only that Indian medical staff also conducted various online training sessions for the medical fraternity of SAARC and other countries which eventually helped them in preparing effectively tackling this virus.[2]
Apart from these initiatives, India also helped its neighbour by evacuating their people from different parts of the World when the lockdown was enforced in those countries
India is world leader in manufacturing of the vaccinnes, almost 50 percent of global demand for immunizations are met by India. So no doubt India played a significant role in the fight against various diseases one of the largest manufacturers of pharmaceutical drugs and a home to half a dozen vaccine makers for various diseases like polio, rotavirus, meningitis, measles, pneumonia, tuberculosis, mumps, rubella and so on. These vaccine makers include Serum Institute of India (AstraZeneca), Bharat Biotech (Covaxin), Biological E. Ltd, Cadila Healthcare Ltd (ZyCoV-D), Hetero Biopharma and so on. Several other Indian vaccine manufacturing companies, including Dr Reddy’s Laboratories (Sputnik V), Biological E Limited (Janssen Ad26.COV2.S and Bio E COVID-19), Aurobindo Pharma (UB-612) and Indian Immunologicals (Live attenuated SARSCoV-2 vaccine developed by Griffith University), have also obtained licences to manufacture vaccine candidates developed in other countries. Amid the novel COVID-19 pandemic, the Indian firms, for example, SII, has started developing anti-viral vaccines collaborating with the United Kingdom and the United States.
In this background India started its Vaccine Maitri diplomacy has enhanced its credibility as a leading and reliable vaccine producer in the new world order, where equitable access to vaccines had become a challenge which can be further substantiated by the statement of WHO Director-General, Dr Tedros Adhanom during his speech in the January 2021 session, expressed concern over unequal access to COVID-19 vaccines where humankind has been facing ‘catastrophic moral failures’. He added, ‘the developed countries monopolized the Pfizer and Moderna vaccines for their populations’ and failed to ensure access to vaccines in the developing countries. In stark contrast to this statement, India has taken a humanitarian view through its ‘Vaccine Maitri’ initiative. Days after vaccinating some of its population, New Delhi had started delivering millions of doses of its COVID-19 vaccines to the SAARC countries including Myanmar and other parts of the world.
Keeping its commitment of the ‘Neighbourhood First’ policy, India started supplying the initial consignment of Covishield and Covaxin to its immediate neighbour mostly belonging to SAARC Countries – Afghanistan, Bhutan, Bangladesh, Nepal, Maldives, Sri Lanka and Myanmar .[3] It is worth mentioning that the SII manufactures the Covishield vaccine with the help of AstraZeneca and Oxford University. In addition, Covaxin has been locally developed and manufactured by Bharat Biotech[4]. Besides this, the SII has also signed a multi-million dollar contract with Bill and Melinda Gates Foundation. As a part of this agreement, India has demonstrated its humanitarian approach by agreeing to provide GAVI (Global Alliance for Vaccine and Immunisation), and its COVAX facility with 100 million vaccine jabs. In addition, India had shown its commitment to helping 95 underdeveloped countries worldwide, focusing on those in its immediate neighbourhood.[5]
Bangladesh Health Minister, “India had remained by Bangladesh during the (1971) Liberation War, and today, when the pandemic is shaking the world, India again accompanied gifts of vaccines, acknowledged India response [6]
The approach of India also reflects its respect for India International Human Rights Law, namely under the UDHR, 1948 and ICCPR 1966. For, eg Art.7 of the UDHR talks about the equality before the law and Art.3 which talks about right to life. Similarly, Art 2 and Art 6, which talks about right to equality and right to life respectively. Another important aspect of these initiatives of India can be traced to Art 25 of the UDHR, which talks about to right to health which is of paramount importance during the Covid 19 specially keeping in mind the divide between the developed and developing countries pertaining to access to health facilities.[7]
The Indian response was well acknowledged globally also as is evident from various global leaders’ tweets and messages from the WHO.[8] India’s proactive approach during this crisis, whether in terms of setting the global agenda or engaging in multilateral diplomacy, has highlighted India’s global health diplomacy (by supplying drugs and essential medicines, sending teams of doctors, evacuating people in distress from most infected areas and partnering with countries for vaccine development) for global good.[9]
In a nutshell, India really followed spirit of 'Vasudhaiva Kutumbakam' (regarding the world as one family) has initially supported with supply of medicines to over 150 countries besides COVID-19 vaccine supply to over 75 nations from India
During the initial outbreak of COVID 19, India developed an indigenous application namely, Arogya Setu app in a very short time for tracking and tracing COVID-19 patients which helped in controlling the spread of the deadly virus. Similarly, later on India developed Co-Win portal, which is used for vaccination India fight against Covid 19, got a boost due to Cowin app. Cowin reflects the citizen-centric design of India’s vaccination programme. The portal has a simple user interface to register and select a convenient facility, with an option to choose the vaccine type. A digital vaccine certificate is delivered in a QR-code via a text message, or a printed copy at the facility. In fact, immunization coverage in rural and hard-to-reach areas is higher than the national average. Real-time online dashboards allow programme managers to visualize and disaggregate demographic data on vaccine coverage, consumption, and waste.
India took a step to make Co-Win open source for all countries to access, adapt and use. This is perhaps the first time that any country is making a software platform developed by its public sector open for the world.[10]
COVID-19 pandemic crisis exacerbates the importance of a hidden form of social inequality, digital inequalities. Indeed, differences exist between individuals and social groups in terms of access to technologies[11] but also in terms of their capacity to obtain benefices from their use of technology by making Cowin a open source for all the countries, India tries its bit to reduce this digital divide From the above arguments, it can be confidently said that India’s vaccine/health diplomacy in giving humanitarian and economic aid has drawn the world’s attention and neighbouring countries. Through ‘Vande Bharat’ mission, India has endeavoured to develop a model of regional partnerships and proved itself as the first responder to the natural calamities and current health crisis in its neighbourhood during the first wave of COVID-19 and also India firmly believes that if the World have to come out effectively from the Covid 19, we need to increase vaccination rates in low- and middle-income countries. As in, it is our collective responsibility to ensure that everyone around the world is vaccinated irrespective of the economic status of his or her country. We are safe only when everyone is safe.
[1] Wendy K. Mariner, Reconsidering Constitutional Protection for Health Information Privacy, (2016) 18 (3) U. Pa. J. Const. L. 975 < https://scholarship.law.upenn.edu/jcl/vol18/iss3/6 > accessed 13 May 2022.
[2] https://www.hindustantimes.com/india-news/mea-announces-covid-19-training-programme-for-saarc-countries/story-eBFdtVLN5geSqyGi2Aw0EJ.html accessed 14th May,2022
[3] https://www.thehindubusinessline.com/news/variety/vaccine-maitri-a-sanjeevini-for-the-world/article62178717.ece accessed on 15th May, 2022
[4] https://www.nytimes.com/2021/11/03/world/asia/covaxin-covid-vaccine-who.html accessed on 15th May, 2022
[5]https://journals.sagepub.com/doi/pdf/10.1177/00219096221079310 accessed on 15th May, 2022
[6] https://www.livemint.com/news/india/india-hands-over-2-million-vaccine-doses-to-bangladesh-11611227496160.html accessed on 15th May, 2022
[7] https://www.imf.org/external/pubs/ft/fandd/2020/09/COVID19-and-global-inequality-joseph-stiglitz.htm accessed on 16th May, 2022
[8] https://economictimes.indiatimes.com/news/politics-and-nation/india-evacuates-maldivians-bangladesh-citizens-from-wuhan-as-part-of-neighbourhood-first-policy/articleshow/73890602.cms?from=mdr accessed on 14th May, 2022
[9] https://theprint.in/india/world-leaders-thank-india-at-unga-session-for-covid-vaccine-shipments-medical-supplies/742394/
[10] https://www.business-standard.com/article/current-affairs/cowin-goes-global-india-makes-tech-open-source-142-nations-show-interest-121070501046_1.html accessed on 15th May, 2022
Authors: ASHUTOSH TRIPATHI
Registration ID: 103137 | Published Paper ID: WBL3137
Year : Aug - 2024 | Volume: 2 | Issue: 16
Approved ISSN : 2581-8503 | Country : Delhi, India
DOI Link : https://www.doi-ds.org/doilink/08.2024-62315437/HOW INDIA STOOD UP TO IT’s TITLE AS “PHARMACY